Biofrontera announced the appointment of George Jones as chief commercial officer, starting August 25. In this role, Jones will oversee the company’s commercial functions, including sales, marketing, and market access. He will report directly to CEO Hermann Luebbert.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BFRI:
- Biofrontera, Inc. (BFRI) Q2 Earnings Cheat Sheet
- Biofrontera Inc. files to sell 13.6M shares of common stock for holders
- Biofrontera Finalizes Acquisition of U.S. Ameluz Rights
- Biofrontera Restructures U.S. Rights with $11M Investment
- Biofrontera Inc. price target raised to $10 from $8 at Roth Capital